Sweden· SE-20250909000043
Nintedanib Bioglan 150 mg Kapsel, mjuk
A medicinal product containing nintedanib esylate, registered in Sweden by Bioglan AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Nintedanib Esylate
- Manufacturer
- Bioglan AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20250909000043
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nintedanib esylate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNINTEDANIB ACCORDAccord Healthcare S.L.U., Barcelona
- FinlandNintedanib AccordAccord Healthcare S.L.U.
- BelgiumNintedanib Accord 150 mgAccord Healthcare
- IrelandNintedanib Accord 150 mg soft capsulesAccord Healthcare S.L.U.
- NorwayNintedanib ZentivaZentiva k.s.
- United StatesnintedanibSandoz Inc
- GermanyNintedanib AlAliud Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Nintedanib Accordpharma, Nintedanib Ratiopharm
- Cyprus · Nintedanib Teva
- Germany · Nintedanib Al, Nintedanib Ipf Al
- Denmark · Nintedanib Bioglan, Nintedanib Teva
- Estonia · Nintedanib Stada
- Finland · Bioglan, Nintedanib Bioglan
- United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Eugia (Uk)
- Hungary · Lunidoc
- Iceland · Nintedanib Demo
- Luxembourg · Nintedanib Teva
- Netherlands · Nintedanib Reig Jofre, Nintedanib Tillomed
- Norway · Nintedanib Zentiva
- Portugal · Nintedanib Bravet, Nintedanib Teva Pharma
- Romania · Gevesla, Nintedanib Teva
- Slovakia · Gevesla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4bfbc472-4f91-41ca-81f7-44037b2d95ae GET /v1/drugs/4bfbc472-4f91-41ca-81f7-44037b2d95ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20250909000043",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20250909000043",
"product_doc_link": "https://docetp.mpa.se/LMF/Nintedanib%20Bioglan%20capsule%2C%20soft%20SmPC_09001bee84fc8d2d.pdf"
}See everything about nintedanib esylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.